Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | New Christie Assure Program Revolutionizes VeinViewer Utilization Services at U.S. HospitalsFive-year program expected to lead industry in utilization training, clinical education and warranty offerings
Chris Schnee, general manager and vice president of sales and marketing at Christie Medical Holdings, said, “Our extensive multi-year Assure Program is a first in the vascular imaging device industry. Each element of this new program not only demonstrates Christie’ The Christie Assure program was built by executing a thorough Voice of Customer survey and addressing customer priorities. Customers told Christie they wanted the company to help them achieve the same results proven in multiple clinical studies. They also wanted to have the confidence that the company standing behind the technology is committed for the long term. Schnee continued: “Through Christie Assure, we achieve customer support at a higher level than I have seen anywhere previously in my career.” The Christie Assure Program: 5‑Year Utilization Training Beyond “Button Pushing” Hands-on Utilization Training is taught by Clinical Applications Consultants (CACs), nurses skilled in venipuncture procedures, IV policy, procedure development and hospital-wide device implementation. The program offers in-depth training to hospital staff to bolster the VeinViewer integration; Clinical studies have proven the benefits of VeinViewer technology with results showing up to a 100 percent increase in first stick success rates, up to a 100 percent increase in patient satisfaction ratings and a 50 percent decrease in medically unnecessary PICC lines. The goal is to maximize the positive return each facility receives from its investment and to improve patient care. 5-Year Clinical Education Surpasses Typical “In-Service” Support The five-year clinical education component offered under the Christie Assure Program includes VeinViewer implementation that surpasses the “in-service” support that typically accompanies the sale of products. The Clinical Education program offers both product education and implementation managed and delivered by a CAC. The program teaches advanced concepts of using VeinViewer, proper techniques for visualization, critical thinking skills and scenarios – all to help improve overall vascular access and protocol adoption. Clinical assessment of the IV site is key and VeinViewer is the only device of its kind to provide Pre, During and Post-access (PDP) vascular visualization benefits, elevating it from a simple vein finder to providing exclusive HD imaging quality benefits. Training beyond the initial needlestick and even beyond the first IV placement is critical to full utilization and benefiting patient care and patient care economics. Through this program, VeinViewer users stay current on the latest innovations in medical devices, such as near-infrared technologies in peripheral vascular access, and guidance from key industry bodies that set national standards. 5-Year Warranty and Upgrade Path Eliminates Ongoing Total Cost of Ownership Concerns Christie’ Customers should review the Christie Assure Program in detail for relevant terms that apply. VeinViewer technology backed by Christie’ VeinViewer technology was developed with aid of the engineering capabilities and resources of parent company Christie Digital Systems, a leading global visual technology firm with more than 80 years of experience in the projection systems industry. VeinViewer is the first and only device on the market to use: harmless near-infrared light, DLP® technologies, exclusive technology such as Active Vascular Imaging Navigation (AVIN™) To learn more about Christie® About Christie Medical Holdings, Inc. Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|